Detalles de la búsqueda
1.
Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial.
Eur Heart J
; 38(29): 2264-2276, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28430910
2.
Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome.
Sci Rep
; 11(1): 7480, 2021 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33820931
3.
Effect of Ezetimibeâ¯+â¯Pitavastatin on Cardiovascular Outcomes in Patients with ST-Segment Elevation Myocardial Infarction (from the HIJ-PROPER Study).
Am J Cardiol
; 132: 15-21, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32773226
4.
Targeting high-sensitivity C-reactive protein levels in acute coronary syndrome patients undergoing contemporary lipid-lowering therapy: a sub-analysis of the HIJ-PROPER trial.
J Cardiol
; 75(5): 500-506, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31699568
5.
The Effects of Lipid-Lowering Therapy on Serum Eicosapentaenoic Acid to Arachidonic Acid Ratio: An HIJ-PROPER Sub-Analysis.
J Cardiovasc Pharmacol Ther
; 25(6): 548-555, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32567339
6.
Impact of age on clinical outcomes of antihypertensive therapy in patients with hypertension and coronary artery disease: A sub-analysis of the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease.
J Clin Hypertens (Greenwich)
; 22(6): 1070-1079, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32475050
7.
Effect of Aggressive Lipid-Lowering Therapy in Single-Vessel vs. Multivessel Coronary Artery Disease Patients With Acute Coronary Syndromeã- Heart Institute of Japan-Proper Level of Lipid Lowering With Pitavastatin and Ezetimibe in Acute Coronary Syndrome (HIJ-PROPER) Substudy.
Circ Rep
; 2(2): 128-134, 2020 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33693218
8.
Polyunsaturated Fatty Acid Impact on Clinical Outcomes in Acute Coronary Syndrome Patients With Dyslipidemia: Subanalysis of HIJ-PROPER.
J Am Heart Assoc
; 8(16): e012953, 2019 08 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31390907
9.
Predictive Value of Baseline High-Sensitivity C-Reactive Protein Level and Renal Function for Patients With Acute Coronary Syndrome Undergoing Aggressive Lipid-Lowering Therapy: A Subanalysis of HIJ-PROPER.
Am J Cardiol
; 122(11): 1817-1823, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30270178
10.
Baseline serum sitosterol level as predictor of adverse clinical events in acute coronary syndrome patients with dyslipidaemia: A sub-analysis of HIJ-PROPER.
Atherosclerosis
; 274: 139-145, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29772482
11.
Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
J Cardiol
; 69(3): 536-541, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27349705
12.
Impact of visit-to-visit variability and systolic blood pressure control on subsequent outcomes in hypertensive patients with coronary artery disease (from the HIJ-CREATE substudy).
Am J Cardiol
; 116(2): 236-42, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25966826
13.
Reply to: "Call for an ezetimibe effectivess test".
Atherosclerosis
; 278: 335, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30278989
14.
Chronic kidney disease and long-term outcomes of myocardial infarction.
Int J Cardiol
; 167(6): 2490-5, 2013 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22569317
15.
Efficacy of the combination of amlodipine and candesartan in hypertensive patients with coronary artery disease: a subanalysis of the HIJ-CREATE study.
J Cardiol
; 62(4): 217-23, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23778009
Resultados
1 -
15
de 15
1
Próxima >
>>